CAGRLINTIDE GLP-1 S 5MG 5MG

Categories:

CAGRLINTIDE GLP-1 S is a research-use-only peptide designed for laboratory evaluation. This compound is presented as a 5 mg vial for controlled experiments. Always intended for research purposes only and not for human or animal therapeutic applications. For research use only.

⚠️ RESEARCH USE ONLY

This product is for R&D purposes only and is not approved for human or veterinary use.

$39.00

⚠️ RESEARCH USE ONLY

This product is for R&D purposes only and is not approved for human or veterinary use.

CAGRLINTIDE GLP-1 S 5MG 5MG

Categories:

CAGRLINTIDE GLP-1 S is a research-use-only peptide designed for laboratory evaluation. This compound is presented as a 5 mg vial for controlled experiments. Always intended for research purposes only and not for human or animal therapeutic applications. For research use only.

$39.00

⚠️ RESEARCH USE ONLY

This product is for R&D purposes only and is not approved for human or veterinary use.

CAGRLINTIDE GLP-1 Research Peptide

CAGRLINTIDE GLP-1 (Glucagon-Like Peptide-1)

CAGRLINTIDE GLP-1 is a synthetic research-use-only peptide derived from the GLP-1 (glucagon-like peptide-1) family, commonly studied for its potential roles in metabolic regulation, neuroendocrine function, and gastrointestinal physiology. This peptide is utilized in academic, pharmaceutical, and preclinical research settings to investigate mechanisms of action in conditions such as diabetes, obesity, and gastrointestinal disorders.

Research Context

GLP-1 is a well-characterized incretin hormone produced in the intestinal L-cells upon ingestion of food. It plays a critical role in glucose homeostasis by stimulating insulin secretion and suppressing glucagon release, particularly in response to elevated blood glucose levels. Beyond its metabolic effects, GLP-1 also influences gut motility, appetite regulation, and neuroendocrine signaling, making it a subject of significant interest in translational research.

Research Overview

CAGRLINTIDE GLP-1 is a truncated or modified variant of endogenous GLP-1 peptides, designed for stability and prolonged half-life in preclinical models. Its research applications include evaluating therapeutic potential in metabolic diseases, studying its impact on pancreatic β-cell function, and exploring neuroprotective or gastrointestinal regulatory effects in controlled experimental settings.

Key Research Focus Areas

  • Metabolic Regulation: Investigation of GLP-1’s role in insulin secretion, glucose tolerance, and potential anti-diabetic effects in preclinical models.
  • Gastrointestinal Physiology: Assessment of peptide-induced gut motility, appetite suppression, and gastrointestinal hormone interactions.
  • Neuroendocrine Signaling: Evaluation of GLP-1’s effects on neuronal circuits involved in glucose sensing and autonomic function.
  • Preclinical Toxicology: Safety profiling in controlled experimental conditions to evaluate potential off-target effects.
  • Drug Discovery: Use as a model to develop GLP-1 receptor agonists or antagonists for therapeutic applications.

Important Disclaimers

This peptide is for research purposes only and is not intended for human or animal consumption. Its use must comply with applicable regulatory guidelines, institutional policies, and ethical standards. Always follow standard laboratory procedures for handling, storage, and disposal of research chemicals to ensure safety. This product is not intended to diagnose, treat, cure, or prevent any disease. Researchers are responsible for obtaining proper approvals and permissions before use. Unauthorized distribution or use is strictly prohibited.

For research use only. Not for human or animal consumption.

Reviews

There are no reviews yet.

Be the first to review “CAGRLINTIDE GLP-1 S 5MG 5MG”

Your email address will not be published. Required fields are marked *

Related Products

Age Verification!

*By continuing, you confirm eligibility and legal compliance.